---
title: "Publications"
permalink: /publications/
author_profile: true
---

For a complete and up-to-date list visit **PubMed**:  
[https://pubmed.ncbi.nlm.nih.gov/?term=Avgeris+M&sort=date](https://pubmed.ncbi.nlm.nih.gov/?term=Avgeris+M&sort=date)

## Journal Articles

**KMT2C inactivation leads to PTEN downregulation and tolerance to DNA damage during cell cycle progression**  
Rampias T, Goutas A, Karagiannis D, Kanaki Z, Makri A, Hoxhallari L, Koukouzeli FE, Paraskevopoulou V, Tsouraki D, Paschalidis N, **Avgeris M**, Scorilas A, Klinakis A  
**NPJ Precis Oncol.** 2025;9(1):336.  
PubMed: [41152370](https://pubmed.ncbi.nlm.nih.gov/41152370/) · DOI: [10.1038/s41698-025-01101-6](https://doi.org/10.1038/s41698-025-01101-6)

---

**Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients**  
Pilala KM, Koroneou S, Papadimitriou MA, Panoutsopoulou K, Soureas K, Giagkos GC, Levis P, Linardoutsos D, Stravodimos K, **Avgeris M**, Scorilas A  
**Int J Cancer.** 2026;158(3):763–774.  
PubMed: [40923330](https://pubmed.ncbi.nlm.nih.gov/40923330/) · DOI: [10.1002/ijc.70147](https://doi.org/10.1002/ijc.70147)

---

**NEAT1 lncRNA overexpression results in short-term progression and poor treatment outcome in childhood B-ALL**  
Xagorari M, Marmarinos A, Doganis D, Nikita M, Magkou E, Sfetsiori AE, Baka M, Kossiva L, Pasparaki S, Soldatou A, Tsolia M, Scorilas A, Gourgiotis D, **Avgeris M**  
**Br J Haematol.** 2025;207(6):2475–2485.  
PubMed: [40888247](https://pubmed.ncbi.nlm.nih.gov/40888247/) · DOI: [10.1111/bjh.70127](https://doi.org/10.1111/bjh.70127)

---

**Long-term effects of SARS-CoV-2 infection on children’s vasculature**  
Karaviti D, Charakida M, Dimopoulou D, Marmarinos A, Papadaki M, Maritsi D, Spyridis N, **Avgeris M**, Gourgiotis D, Tsolia M  
**Pediatr Infect Dis J.** 2025;44(8):792–797.  
PubMed: [40294329](https://pubmed.ncbi.nlm.nih.gov/40294329/) · DOI: [10.1097/INF.0000000000004786](https://doi.org/10.1097/INF.0000000000004786)

---

**Lifestyle and biochemical parameters that may hamper immune responses in pediatric patients after immunization with the BNT162b2 mRNA COVID-19 vaccine**  
Damianaki A, Marmarinos A, **Avgeris M**, Gourgiotis D, Vlachopapadopoulou EA, Charakida M, Tsolia M, Kossiva L  
**Diseases.** 2025;13(3):78.  
PubMed: [40136618](https://pubmed.ncbi.nlm.nih.gov/40136618/) · DOI: [10.3390/diseases13030078](https://doi.org/10.3390/diseases13030078)

---

**Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome**  
Soureas K, Malandrakis P, Papadimitriou MA, Minopoulos C, Ntanasis-Stathopoulos I, Liacos CI, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, **Avgeris M**, Terpos E  
**Blood Cancer J.** 2025;15(1):41.  
PubMed: [40089465](https://pubmed.ncbi.nlm.nih.gov/40089465/) · DOI: [10.1038/s41408-025-01248-2](https://doi.org/10.1038/s41408-025-01248-2)

---

**Identification of Oncogene-Induced Senescence-Associated MicroRNAs**  
Foutadakis S, Soureas K, Roupakia E, Besta S, **Avgeris M**, Kolettas E  
**Methods Mol Biol.** 2025;2906:189–213.  
PubMed: [40082357](https://pubmed.ncbi.nlm.nih.gov/40082357/) · DOI: [10.1007/978-1-0716-4426-3_11](https://doi.org/10.1007/978-1-0716-4426-3_11)

---

**Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome**    
Pilala KM, Panoutsopoulou K, Papadimitriou MA, Soureas K, Scorilas A, **Avgeris M**  
**Mol Ther.** 2025;33(2):447–464.  
PubMed: [39659016](https://pubmed.ncbi.nlm.nih.gov/39659016/) · DOI: [10.1016/j.ymthe.2024.12.003](https://doi.org/10.1016/j.ymthe.2024.12.003)

---

**Seroprevalence of diphtheria, tetanus and pertussis antibodies and Tdap vaccination in pregnant women in Greece – A cross-sectional study**  
Papailiou S, Soldatou A, Marmarinos A, **Avgeris M**, Papathoma E, Sindos M, Georgantzi S, Rodolakis A, Iacovidou N, Gourgiotis D, Tsolia M  
**Vaccine.** 2024;42(26):126435.  
PubMed: [39437646](https://pubmed.ncbi.nlm.nih.gov/39437646/) · DOI: [10.1016/j.vaccine.2024.126435](https://doi.org/10.1016/j.vaccine.2024.126435)

---

**CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients**  
Papadimitriou MA, Pilala KM, Panoutsopoulou K, Levis P, Kotronopoulos G, Kanaki Z, Loules G, Zamanakou M, Linardoutsos D, Sideris DC, Stravodimos K, Klinakis A, Scorilas A, **Avgeris M**  
**Mol Ther Oncol.** 2024;32(2):200818.  
PubMed: [38966038](https://pubmed.ncbi.nlm.nih.gov/38966038/) · DOI: [10.1016/j.omton.2024.200818](https://doi.org/10.1016/j.omton.2024.200818)

---

**MIR145 core promoter methylation in pretreatment cell-free DNA: A liquid biopsy tool for muscle-invasive bladder cancer treatment outcome**  
Pilala KM, Kotronopoulos G, Levis P, Giagkos GC, Stravodimos K, Vassilacopoulou D, Scorilas A, **Avgeris M**  
**JCO Precis Oncol.** 2024;8:e2300414.  
PubMed: [38579191](https://pubmed.ncbi.nlm.nih.gov/38579191/) · DOI: [10.1200/PO.23.00414](https://doi.org/10.1200/PO.23.00414)

---

**Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome**  
Soureas K, Papadimitriou MA, Malandrakis P, Papanota AM, Adamopoulos PG, Ntanasis-Stathopoulos I, Liacos CI, Gavriatopoulou M, Sideris DC, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E, **Avgeris M**  
**Br J Haematol.** 2024;204(5):1790–1800.  
PubMed: [38414235](https://pubmed.ncbi.nlm.nih.gov/38414235/) · DOI: [10.1111/bjh.19332](https://doi.org/10.1111/bjh.19332)

---

**SARS-CoV-2 antibody kinetics in unvaccinated hospitalized children with COVID-19**  
Dimopoulou D, Charakida M, Marmarinos A, Karaviti D, **Avgeris M**, Gourgiotis D, Tsolia MN  
**Pediatr Infect Dis J.** 2024;43(6):536–542.  
PubMed: [38372544](https://pubmed.ncbi.nlm.nih.gov/38372544/) · DOI: [10.1097/INF.0000000000004301](https://doi.org/10.1097/INF.0000000000004301)

---

**28S rRNA-derived fragments represent an independent molecular predictor of short-term relapse in prostate cancer**  
Diamantopoulos MA, Georgoulia KK, Levis P, Kotronopoulos G, Stravodimos K, Kontos CK, **Avgeris M**, Scorilas A  
**Int J Mol Sci.** 2023;25(1):239.  
PubMed: [38203408](https://pubmed.ncbi.nlm.nih.gov/38203408/) · DOI: [10.3390/ijms25010239](https://doi.org/10.3390/ijms25010239)

---

**Spike-Seq: An amplicon-based high-throughput sequencing approach for the sensitive detection and characterization of SARS-CoV-2 genetic variations in environmental samples**  
Adamopoulos PG, Diamantopoulos MA, Boti MA, Zafeiriadou A, Galani A, Kostakis M, Markou A, Sideris DC, **Avgeris M**, Thomaidis NS, Scorilas A  
**Sci Total Environ.** 2024;914:169747.  
PubMed: [38159750](https://pubmed.ncbi.nlm.nih.gov/38159750/) · DOI: [10.1016/j.scitotenv.2023.169747](https://doi.org/10.1016/j.scitotenv.2023.169747)

---

**miRNA-based technologies in cancer therapy** *(Review)*  
Pagoni M, Cava C, Sideris DC, **Avgeris M**, Zoumpourlis V, Michalopoulos I, Drakoulis N  
**J Pers Med.** 2023;13(11):1586.  
PubMed: [38003902](https://pubmed.ncbi.nlm.nih.gov/38003902/) · DOI: [10.3390/jpm13111586](https://doi.org/10.3390/jpm13111586)

---

**Cancer quiescence: non-coding RNAs in the spotlight** *(Review)*  
Soureas K, Papadimitriou MA, Panoutsopoulou K, Pilala KM, Scorilas A, **Avgeris M**  
**Trends Mol Med.** 2023;29(10):843–858.  
PubMed: [37516569](https://pubmed.ncbi.nlm.nih.gov/37516569/) · DOI: [10.1016/j.molmed.2023.07.003](https://doi.org/10.1016/j.molmed.2023.07.003)

---

**Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer**  
Liu Y, Gong W, Panoutsopoulou K, Singer-Cornelius T, Augustin K, Bronger H, Kiechle M, Dorn J, Scorilas A, **Avgeris M**, Magdolen V, Dreyer T  
**Am J Cancer Res.** 2023;13(6):2471–2487.  
PubMed: [37424802](https://pubmed.ncbi.nlm.nih.gov/37424802/)

---

**First trimester maternal plasma proteomic changes predictive of spontaneous moderate/late preterm delivery**  
Mavreli D, Theodora M, Lambrou G, **Avgeris M**, Papantoniou N, Treager-Synodinos J, Daskalakis G, Kolialexi A  
**J Matern Fetal Neonatal Med.** 2023;36(2):2232074.  
PubMed: [37424082](https://pubmed.ncbi.nlm.nih.gov/37424082/) · DOI: [10.1080/14767058.2023.2232074](https://doi.org/10.1080/14767058.2023.2232074)

---

**Deregulated expression of IL-37 in patients with bladder urothelial cancer: The diagnostic potential of the IL-37e isoform**  
Papasavva M, Amvrosiou S, Pilala KM, Soureas K, Christodoulou P, Ji Y, Stravodimos K, Xu D, Scorilas A, **Avgeris M**, Christodoulou MI  
**Int J Mol Sci.** 2023;24(11):9258.  
PubMed: [37298214](https://pubmed.ncbi.nlm.nih.gov/37298214/) · DOI: [10.3390/ijms24119258](https://doi.org/10.3390/ijms24119258)

---

**miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma**  
Papadimitriou MA, Soureas K, Papanota AM, Tsiakanikas P, Adamopoulos PG, Ntanasis-Stathopoulos I, Malandrakis P, Gavriatopoulou M, Sideris DC, Kastritis E, **Avgeris M**, Dimopoulos MA, Terpos E, Scorilas A  
**J Transl Med.** 2023;21(1):245.  
PubMed: [37024879](https://pubmed.ncbi.nlm.nih.gov/37024879/) · DOI: [10.1186/s12967-023-04034-5](https://doi.org/10.1186/s12967-023-04034-5)

---

**Short-term starvation potentiates the efficacy of chemotherapy in triple-negative breast cancer via metabolic reprogramming**  
Pateras IS, Williams C, Gianniou DD, Margetis AT, **Avgeris M**, Rousakis P, Legaki AI, Mirtschink P, Zhang W, Panoutsopoulou K, Delis AD, Pagakis SN, Tang W, Ambs S, Warpman Berglund U, Helleday T, Varvarigou A, Chatzigeorgiou A, Nordström A, Tsitsilonis OE, Trougakos IP, Gilthorpe JD, Frisan T  
**J Transl Med.** 2023;21(1):169.  
PubMed: [36869333](https://pubmed.ncbi.nlm.nih.gov/36869333/) · DOI: [10.1186/s12967-023-03935-9](https://doi.org/10.1186/s12967-023-03935-9)

---

**Evaluation of the small heat shock protein family members HSPB2 and HSPB3 in bladder cancer prognosis and progression**  
Gianniou DD, Sklirou AD, Papadimitriou MA, Pilala KM, Stravodimos K, **Avgeris M**, Scorilas A, Trougakos IP  
**Int J Mol Sci.** 2023;24(3):2609.  
PubMed: [36768927](https://pubmed.ncbi.nlm.nih.gov/36768927/) · DOI: [10.3390/ijms24032609](https://doi.org/10.3390/ijms24032609)

---

**Preoperative cell-free DNA (cfDNA) in muscle-invasive bladder cancer treatment outcome**  
Papadimitriou MA, Levis P, Kotronopoulos G, Stravodimos K, **Avgeris M**, Scorilas A  
**Clin Chem.** 2023;69(4):399–410.  
PubMed: [36738246](https://pubmed.ncbi.nlm.nih.gov/36738246/) · DOI: [10.1093/clinchem/hvac218](https://doi.org/10.1093/clinchem/hvac218)

---

**Advancing desulfurization in the model biocatalyst *Rhodococcus qingshengii* IGTS8 via an in locus combinatorial approach**  
Martzoukou O, Amillis S, Glekas PD, Breyanni D, **Avgeris M**, Scorilas A, Kekos D, Pachnos M, Mavridis G, Mamma D, Hatzinikolaou DG  
**Appl Environ Microbiol.** 2023;89(2):e01970-22.  
PubMed: [36688659](https://pubmed.ncbi.nlm.nih.gov/36688659/) · DOI: [10.1128/aem.01970-22](https://doi.org/10.1128/aem.01970-22)

---

**tRNA-derived small RNA 3′U-tRFValCAC promotes tumour migration and early progression in ovarian cancer**  
Panoutsopoulou K, Magkou P, Dreyer T, Dorn J, Obermayr E, Mahner S, van Gorp T, Braicu I, Magdolen V, Zeillinger R, **Avgeris M**, Scorilas A  
**Eur J Cancer.** 2023;180:134–145.  
PubMed: [36599181](https://pubmed.ncbi.nlm.nih.gov/36599181/) · DOI: [10.1016/j.ejca.2022.11.033](https://doi.org/10.1016/j.ejca.2022.11.033)

---

**Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer**  
Panoutsopoulou K, Liu Y, **Avgeris M**, Dreyer T, Dorn J, Magdolen V, Scorilas A  
**Clin Biochem.** 2023;114:43–51.  
PubMed: [36502883](https://pubmed.ncbi.nlm.nih.gov/36502883/) · DOI: [10.1016/j.clinbiochem.2022.12.004](https://doi.org/10.1016/j.clinbiochem.2022.12.004)

---

**First trimester maternal plasma aberrant miRNA expression associated with spontaneous preterm birth**  
Mavreli D, Theodora M, **Avgeris M**, Papantoniou N, Antsaklis P, Daskalakis G, Kolialexi A  
**Int J Mol Sci.** 2022;23(23):14972.  
PubMed: [36499299](https://pubmed.ncbi.nlm.nih.gov/36499299/) · DOI: [10.3390/ijms232314972](https://doi.org/10.3390/ijms232314972)

---

**Corrigendum to “Delta SARS-CoV-2 variant is entirely substituted by the omicron variant during the fifth COVID-19 wave in Attica region”**  
Galani A, Markou A, Dimitrakopoulos L, Kontou A, Kostakis M, Kapes V, Diamantopoulos MA, Adamopoulos PG, **Avgeris M**, Lianidou E, Scorilas A, Paraskevis D, Tsiodras S, Dimopoulos MA, Thomaidis N  
**Sci Total Environ.** 2023;860:160544.  
PubMed: [36460542](https://pubmed.ncbi.nlm.nih.gov/36460542/) · DOI: [10.1016/j.scitotenv.2022.160544](https://doi.org/10.1016/j.scitotenv.2022.160544)

---

**Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome**  
Pilala KM, Papadimitriou MA, Panoutsopoulou K, Barbarigos P, Levis P, Kotronopoulos G, Stravodimos K, Scorilas A, **Avgeris M**  
**Mol Ther Nucleic Acids.** 2022;30:311–322.  
PubMed: [36320325](https://pubmed.ncbi.nlm.nih.gov/36320325/) · DOI: [10.1016/j.omtn.2022.10.001](https://doi.org/10.1016/j.omtn.2022.10.001)
